Bioequivalence and safety assessment of sorafenib tosylate tablets in healthy Chinese subjects under fasting conditions

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-04-14
DOI
https://doi.org/10.3389/fphar.2025.1470095
Citations
1
Primary Topic
Pharmacogenetics and Drug Metabolism
Type
article
Field-Weighted Citation Impact
1.56
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bioequivalence and safety assessment of sorafenib tosylate tablets in healthy Chinese subjects under fasting conditions

Xijing Chen, Jiye Aa, Yun Zhang, Hong Peng et al.
1 citations
Frontiers in Pharmacology
Pharmacogenetics and Drug Metabolism
1.56
article

Bioequivalence and safety assessment of sorafenib tosylate tablets in healthy Chinese subjects under fasting conditions

Xijing Chen, Jiye Aa, Yun Zhang, Hong Peng, Zhaoyu Wang
article en
1 citations

Abstract

No abstract available for this paper.
Frontiers in PharmacologyVol. 16
China Pharmaceutical University (CN)
Good health and well-being
Openalex Percentile: Top 21%
Pharmacogenetics and Drug Metabolism
1.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Bioequivalence and safety assessment of sorafenib tosylate tablets in healthy Chinese subjects under fasting conditions — Xijing Chen, Jiye Aa, et al. · Frontiers in Pharmacology (2025) | TGRS Research Map | TGRS